{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:16:57Z","timestamp":1783675017502,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009308","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000}}],"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI109680-01"],"award-info":[{"award-number":["1U19AI109680-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R41AI138964-01"],"award-info":[{"award-number":["R41AI138964-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Mayaro virus (MAYV) is an alphavirus endemic to South and Central America associated with sporadic outbreaks in humans. MAYV infection causes severe joint and muscle pain that can persist for weeks to months. Currently, there are no approved vaccines or therapeutics to prevent MAYV infection or treat the debilitating musculoskeletal inflammatory disease. In the current study, a prophylactic MAYV vaccine expressing the complete viral structural polyprotein was developed based on a non-replicating human adenovirus V (AdV) platform. Vaccination with AdV-MAYV elicited potent neutralizing antibodies that protected WT mice against MAYV challenge by preventing viremia, reducing viral dissemination to tissues and mitigating viral disease. The vaccine also prevented viral-mediated demise in IFN\u237aR1<jats:sup>-\/-<\/jats:sup>mice. Passive transfer of immune serum from vaccinated animals similarly prevented infection and disease in WT mice as well as virus-induced demise of IFN\u237aR1<jats:sup>-\/-<\/jats:sup>mice, indicating that antiviral antibodies are protective. Immunization with AdV-MAYV also generated cross-neutralizing antibodies against two related arthritogenic alphaviruses\u2013chikungunya and Una viruses. These cross-neutralizing antibodies were protective against lethal infection in IFN\u237aR1<jats:sup>-\/-<\/jats:sup>mice following challenge with these heterotypic alphaviruses. These results indicate AdV-MAYV elicits protective immune responses with substantial cross-reactivity and protective efficacy against other arthritogenic alphaviruses. Our findings also highlight the potential for development of a multi-virus targeting vaccine against alphaviruses with endemic and epidemic potential in the Americas.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009308","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T18:42:49Z","timestamp":1617302569000},"page":"e0009308","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-9109","authenticated-orcid":true,"given":"John M.","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-2763","authenticated-orcid":true,"given":"Nicole N.","family":"Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Kreklywich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiley","family":"Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-6559","authenticated-orcid":true,"given":"Cassilyn E.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3859-6391","authenticated-orcid":true,"given":"Nicholas","family":"Kreklywich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2986-6479","authenticated-orcid":true,"given":"Patricia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Broeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"DeFilippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-2938","authenticated-orcid":true,"given":"Thomas E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-2492","authenticated-orcid":true,"given":"Daniel N.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"10","key":"pntd.0009308.ref001","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3201\/eid0910.030161","article-title":"Mayaro virus in wild mammals, French Guiana","volume":"9","author":"B de Thoisy","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009308.ref002","doi-asserted-by":"crossref","first-page":"973516","DOI":"10.1155\/2013\/973516","article-title":"Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis","volume":"2013","author":"I Assuncao-Miranda","year":"2013","journal-title":"Biomed Res Int"},{"issue":"1","key":"pntd.0009308.ref003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41426-018-0163-5","article-title":"Mayaro: an emerging viral threat?","volume":"7","author":"Y Acosta-Ampudia","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"pntd.0009308.ref004","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00003-18","article-title":"Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages","volume":"3","author":"JL Smith","year":"2018","journal-title":"mSphere"},{"issue":"2","key":"pntd.0009308.ref005","doi-asserted-by":"crossref","DOI":"10.3390\/v10020089","article-title":"The Alphavirus Exit Pathway: What We Know and What We Wish We Knew","volume":"10","author":"RS Brown","year":"2018","journal-title":"Viruses"},{"key":"pntd.0009308.ref006","article-title":"Small Molecule Inhibitors Targeting Chikungunya Virus","author":"N Haese","year":"2020","journal-title":"Current topics in microbiology and immunology"},{"issue":"10","key":"pntd.0009308.ref007","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3201\/eid2110.141660","article-title":"Evolutionary and Ecological Characterization of Mayaro Virus Strains Isolated during an Outbreak, Venezuela, 2010","volume":"21","author":"AJ Auguste","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"pntd.0009308.ref008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/milmed\/141.3.163","article-title":"Inactivated Mayaro vaccine produced in human diploid cell cultures","volume":"141","author":"DM Robinson","year":"1976","journal-title":"Mil Med"},{"issue":"2","key":"pntd.0009308.ref009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(02)00212-7","article-title":"Inhibition of adenovirus infection and adenain by green tea catechins","volume":"58","author":"JM Weber","year":"2003","journal-title":"Antiviral Res"},{"issue":"2","key":"pntd.0009308.ref010","doi-asserted-by":"crossref","first-page":"e0007042","DOI":"10.1371\/journal.pntd.0007042","article-title":"Protective immunity by an engineered DNA vaccine for Mayaro virus","volume":"13","author":"H Choi","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009308.ref011","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1038\/s41598-020-62084-x","article-title":"In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease","volume":"10","author":"MTO Mota","year":"2020","journal-title":"Sci Rep"},{"key":"pntd.0009308.ref012","doi-asserted-by":"crossref","first-page":"591885","DOI":"10.3389\/fimmu.2020.591885","article-title":"Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model","volume":"11","author":"R Kroon Campos","year":"2020","journal-title":"Front Immunol"},{"key":"pntd.0009308.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.05.004","article-title":"Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)","volume":"108","author":"A Dagley","year":"2014","journal-title":"Antiviral Res"},{"issue":"11","key":"pntd.0009308.ref014","doi-asserted-by":"crossref","first-page":"e0006895","DOI":"10.1371\/journal.pntd.0006895","article-title":"Anopheles mosquitoes may drive invasion and transmission of Mayaro virus across geographically diverse regions","volume":"12","author":"M Brustolin","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0009308.ref015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5152\/tpa.2014.2206","article-title":"Vaccination in patients with immunosuppression","volume":"49","author":"A Arvas","year":"2014","journal-title":"Turk Pediatri Ars"},{"issue":"4","key":"pntd.0009308.ref016","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Medical Advisory Committee of the Immune Deficiency F","year":"2014","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"6","key":"pntd.0009308.ref017","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"R Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"pntd.0009308.ref018","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"SG Reed","year":"2013","journal-title":"Nature medicine"},{"issue":"3","key":"pntd.0009308.ref019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"W Akahata","year":"2010","journal-title":"Nat Med"},{"issue":"suppl 5","key":"pntd.0009308.ref020","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","article-title":"Development of Vaccines for Chikungunya Fever","volume":"214","author":"JH Erasmus","year":"2016","journal-title":"The Journal of infectious diseases"},{"issue":"15","key":"pntd.0009308.ref021","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"D Wang","year":"2011","journal-title":"Vaccine"},{"issue":"24","key":"pntd.0009308.ref022","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.vaccine.2019.04.069","article-title":"An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling","volume":"37","author":"EG Dora","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"pntd.0009308.ref023","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8040231","article-title":"A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease","volume":"8","author":"RK Campos","year":"2019","journal-title":"Pathogens"},{"issue":"31","key":"pntd.0009308.ref024","doi-asserted-by":"crossref","first-page":"30675","DOI":"10.18632\/oncotarget.5169","article-title":"Progresses towards safe and efficient gene therapy vectors","volume":"6","author":"S Chira","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"pntd.0009308.ref025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"N Tatsis","year":"2004","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"6","key":"pntd.0009308.ref026","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1590\/0037-8682-0246-2014","article-title":"Emerging alphaviruses in the Americas: Chikungunya and Mayaro","volume":"47","author":"ML Figueiredo","year":"2014","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0009308.ref027","first-page":"29853","article-title":"Global emergence of Alphaviruses that cause arthritis in humans","volume":"5","author":"OW Lwande","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"key":"pntd.0009308.ref028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-319-54567-7_9","volume-title":"Human Virology in Latin America: From Biology to Control","author":"J-C Navarro","year":"2017"},{"issue":"5","key":"pntd.0009308.ref029","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress","volume":"163","author":"JM Fox","year":"2015","journal-title":"Cell"},{"issue":"6","key":"pntd.0009308.ref030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4269\/ajtmh.1967.16.782","article-title":"Patterns of viremia and antibody observed in rhesus monkeys inoculated with chikungunya and other serologically related group A arboviruses","volume":"16","author":"LN Binn","year":"1967","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pntd.0009308.ref031","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4269\/ajtmh.18-0756","article-title":"Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una Viruses","volume":"100","author":"KA Martins","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0009308.ref032","doi-asserted-by":"crossref","first-page":"20399","DOI":"10.1038\/s41598-019-56551-3","article-title":"Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential","volume":"9","author":"EM Webb","year":"2019","journal-title":"Sci Rep"},{"issue":"31","key":"pntd.0009308.ref033","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2012.04.099","article-title":"Cross-protective immunity against o\u2019nyong-nyong virus afforded by a novel recombinant chikungunya vaccine","volume":"30","author":"CD Partidos","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"pntd.0009308.ref034","article-title":"Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models","volume":"8","author":"W Nguyen","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pntd.0009308.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01970-16","article-title":"Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design","volume":"8","author":"A Taylor","year":"2017","journal-title":"mBio"},{"issue":"8","key":"pntd.0009308.ref036","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.03192-15","article-title":"Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus","volume":"90","author":"A Taylor","year":"2016","journal-title":"Journal of virology"},{"issue":"21","key":"pntd.0009308.ref037","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","article-title":"Evolutionary relationships and systematics of the alphaviruses","volume":"75","author":"AM Powers","year":"2001","journal-title":"J Virol"},{"issue":"Pt 2","key":"pntd.0009308.ref038","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/0022-1317-80-2-345","article-title":"Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein","volume":"80","author":"DA Matthews","year":"1999","journal-title":"J Gen Virol"},{"key":"pntd.0009308.ref039","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3389\/fimmu.2019.02563","article-title":"Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease","volume":"10","author":"RM Broeckel","year":"2019","journal-title":"Front Immunol"},{"issue":"14","key":"pntd.0009308.ref040","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1128\/JVI.00373-09","article-title":"Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus","volume":"83","author":"D Safronetz","year":"2009","journal-title":"J Virol"},{"issue":"Pt 3","key":"pntd.0009308.ref041","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1099\/0022-1317-70-3-743","article-title":"Most alphaviruses share a conserved epitopic region on their nucleocapsid protein","volume":"70","author":"I Greiser-Wilke","year":"1989","journal-title":"J Gen Virol"},{"key":"pntd.0009308.ref042","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1743-422X-9-210","article-title":"Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media","volume":"9","author":"A Lynch","year":"2012","journal-title":"Virology journal"},{"issue":"2","key":"pntd.0009308.ref043","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0074-02761993000200020","article-title":"Mayaro virus proteins","volume":"88","author":"JM Mezencio","year":"1993","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"52","key":"pntd.0009308.ref044","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1073\/pnas.1713166114","article-title":"Structural studies of Chikungunya virus maturation","volume":"114","author":"ML Yap","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"D1","key":"pntd.0009308.ref045","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"R Vita","year":"2019","journal-title":"Nucleic acids research"},{"issue":"1","key":"pntd.0009308.ref046","doi-asserted-by":"crossref","DOI":"10.3390\/v11010035","article-title":"Modeling Arboviral Infection in Mice Lacking the Interferon Alpha\/Beta Receptor","volume":"11","author":"A Marin-Lopez","year":"2019","journal-title":"Viruses"},{"issue":"2","key":"pntd.0009308.ref047","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"T Couderc","year":"2008","journal-title":"PLoS Pathog"},{"issue":"22","key":"pntd.0009308.ref048","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"D Hallengard","year":"2014","journal-title":"Journal of virology"},{"issue":"2","key":"pntd.0009308.ref049","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.20090851","article-title":"Type I IFN controls chikungunya virus via its action on nonhematopoietic cells","volume":"207","author":"C Schilte","year":"2010","journal-title":"J Exp Med"},{"issue":"27","key":"pntd.0009308.ref050","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2018.05.095","article-title":"A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections","volume":"36","author":"A Chattopadhyay","year":"2018","journal-title":"Vaccine"},{"issue":"22","key":"pntd.0009308.ref051","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01419-17","article-title":"Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells","volume":"91","author":"S Nair","year":"2017","journal-title":"Journal of virology"},{"issue":"6","key":"pntd.0009308.ref052","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1371\/journal.pone.0000527","article-title":"Human muscle satellite cells as targets of Chikungunya virus infection","volume":"2","author":"S Ozden","year":"2007","journal-title":"PloS one"},{"key":"pntd.0009308.ref053","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.3389\/fmicb.2019.02246","article-title":"Mayaro Virus Replication Restriction and Induction of Muscular Inflammation in Mice Are Dependent on Age, Type-I Interferon Response, and Adaptive Immunity","volume":"10","author":"CM Figueiredo","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"pntd.0009308.ref054","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4049\/jimmunol.160.1.20","article-title":"Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity","volume":"160","author":"AL Gavin","year":"1998","journal-title":"Journal of immunology"},{"issue":"10","key":"pntd.0009308.ref055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/icb.2016.65","article-title":"IgG subclass co-expression brings harmony to the quartet model of murine IgG function","volume":"94","author":"AM Collins","year":"2016","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"pntd.0009308.ref056","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/21505594.2016.1193278","article-title":"Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens","volume":"7","author":"NJ Harmer","year":"2016","journal-title":"Virulence"},{"issue":"4","key":"pntd.0009308.ref057","doi-asserted-by":"crossref","first-page":"e0007316","DOI":"10.1371\/journal.pntd.0007316","article-title":"Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice","volume":"13","author":"MT Arevalo","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0009308.ref058","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"SE Hensley","year":"2007","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"8","key":"pntd.0009308.ref059","doi-asserted-by":"crossref","first-page":"e2969","DOI":"10.1371\/journal.pntd.0002969","article-title":"A novel live-attenuated vaccine candidate for mayaro Fever","volume":"8","author":"WJ Weise","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009308.ref060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000025023","article-title":"An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8","volume":"43","author":"L Mateo","year":"2000","journal-title":"Intervirology"},{"issue":"8","key":"pntd.0009308.ref061","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"MO Lasaro","year":"2009","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"10249","key":"pntd.0009308.ref062","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"FC Zhu","year":"2020","journal-title":"Lancet"},{"issue":"10249","key":"pntd.0009308.ref063","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"PM Folegatti","year":"2020","journal-title":"Lancet"},{"key":"pntd.0009308.ref064","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1743-422X-5-108","article-title":"Discovery of frameshifting in Alphavirus 6K resolves a 20-year enigma","volume":"5","author":"AE Firth","year":"2008","journal-title":"Virology journal"},{"issue":"3","key":"pntd.0009308.ref065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"KM Quinn","year":"2015","journal-title":"The Journal of clinical investigation"},{"issue":"20","key":"pntd.0009308.ref066","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae","volume":"84","author":"H Chen","year":"2010","journal-title":"Journal of virology"},{"key":"pntd.0009308.ref067","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1038\/srep16756","article-title":"Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice","volume":"5","author":"MD Dicks","year":"2015","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009308","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:35:36Z","timestamp":1724754936000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009308"}},"subtitle":[],"editor":[{"given":"Ran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009308","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009308","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}